What does CUSIP 59564R708 represent in this 13F holders report?

CUSIP 59564R708 is the security identifier for BDRX - BIODEXA PHARMACEUTICALS PLC - SPON ADS NEW used to aggregate holder disclosures.

How many institutions held BDRX - BIODEXA PHARMACEUTICALS PLC - SPON ADS NEW in Q3 2023?

5 institutional investors reported BDRX - BIODEXA PHARMACEUTICALS PLC - SPON ADS NEW for Q3 2023. Use the holders table for investor-level position and value details.

BIODEXA PHARMACEUTICALS PLC - SPON ADS NEW (BDRX)

CUSIP: 59564R708

Q3 2023 13F Holders as of 30 Sep 2023

Security type / class: Equity / SPON ADS NEW
Total 13F shares: 12,098
Total 13F value: $58,932
Share change: +12,098
SEC-reported price per share: $4.98
Number of holders: 5
Value change: +$58,932
Number of buys: 5

Security key

59564R708

Report period

Q3 2023

Institutions

Top holders

BDRX full security history Ownership snapshot Full 13F holder table Biodexa Pharmaceuticals Plc SEC filings Biodexa Pharmaceuticals Plc company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of BDRX - BIODEXA PHARMACEUTICALS PLC - SPON ADS NEW (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

Cubist Systematic Strateg...

Disclosed value leader

Cubist Systematic Strateg...

Comparable rows

0/8

Latest evidence

30 Jun 2023

13F Highest disclosed value: $18,247 8 rows are not safely comparable across share classes. Showing 1-6 of 8 holder rows.

Quick read

Cubist Systematic Strategies, LLC has the largest disclosed position value at $18.2K.

0 of 8 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Cubist Systematic Strategies, LLC's linked filing trail.

Disclosed position value Top 5

Cubist Systematic Strategies, LLC $18.2K

MILLENNIUM MANAGEMENT LLC $14K

UBS Group AG $9.8K

TWO SIGMA SECURITIES, LLC $2.6K

Baader Bank Aktiengesellschaft $865

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 8 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
Cubist Systematic Strategies, LLC	13F Company 13F	— denominator unverified	$18,247 265,993 shares	—	30 Jun 2023
MILLENNIUM MANAGEMENT LLC	13F Company 13F	— denominator unverified	$14,035 204,300 shares	—	30 Jun 2023
UBS Group AG	13F Company 13F	— denominator unverified	$9,812 142,208 shares	—	30 Jun 2023
TWO SIGMA SECURITIES, LLC	13F Company 13F	— denominator unverified	$2,598 37,865 shares	—	30 Jun 2023
Baader Bank Aktiengesellschaft	13F Company 13F	— denominator unverified	$865 16,250 shares	—	30 Jun 2023
RHUMBLINE ADVISERS	13F Company 13F	— denominator unverified	$163 2,370 shares	—	30 Jun 2023

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

12,098

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2023 vs Q2 2023 Across Filers

Q2 2023 holders

Q3 2023 holders

Holder diff

Investor	Q2 2023 Shares	Q3 2023 Shares	Share Diff	Share Chg %	Q2 2023 value	Q3 2023 value	Value change	Value Chg %